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Commentary
Recent articles have discussed the obligations 
researchers have to inform study participants 
about their individual research results (Resnik 
2009; Sly et al. 2009). Deciding whether and 
how to inform research participants about risks 
they face in their environment is a challenging 
task. The decision becomes more complicated 
when the research involves measuring bio­
markers of exposure in a study population of 
children. Some ethical questions relate to chil­
dren as research participants, and others are 
specific to biomarker research. Our experience 
reporting biomarker results to the families 
of our study participants provides a concrete 
example that is important to share with the 
research community. We present a summary 
of the biomarker findings of concern, how the 
results were reported to study families and the 
competing perspectives we balanced in decid­
ing to report back unexpected results.
Background
The University of Cincinnati (UC), in con­
junction with the Cincinnati Children’s 
Hospital Medical Center (CCHMC) and 
local breast cancer advocates, forms one of 
four Breast Cancer and the Environment 
Research Centers (BCERCs) established 
in September 2003 with funding from the 
National Institute of Environmental Health 
Sciences and the National Cancer Institute. 
The BCERCs include projects in biology, 
epidemiology, and community outreach and 
education. The unifying research theme is 
based on the hypothesis that chemical, physi­
cal, and social factors in the environment 
interact with genetic factors to affect the 
mammary gland during peripubertal develop­
ment and across the life span in ways that 
may alter breast cancer risk in later life. This 
transdisciplinary research paradigm involves 
biologists, epidemiologists, clinicians, and 
breast cancer advocates (Hiatt et al. 2009).
The specific aims of the epidemiology 
research are to understand more fully the 
impact of environmental factors on pubertal 
maturation in young girls and how puberty 
may serve as a window of susceptibility for 
breast cancer later in life. These objectives 
are predicated on the established association 
between age at menarche and breast cancer 
risk (Clavel­Chapelon 2002). Examination 
of environmental factors and pubertal onset 
could help us better understand breast cancer 
etiologies and inform prevention strategies.
The Greater Cincinnati epidemiol­
ogy project, known as Growing Up Female 
(GUF), recruited 6­ and 7­year­old girls and 
their families from school districts in south­
west Ohio and across the Ohio River in 
northern Kentucky. Recruitment began in 
Spring 2004 in the two school districts. This 
research study was conducted with the over­
sight of the CCHMC Institutional Review 
Board (IRB), and participation of the subjects 
did not occur until after written consent was 
obtained. These early recruits were seen every 
6 months at the district schools during school 
hours. Anthropometric measures, including 
height, weight, and maturation assessment, 
were conducted at each visit. Data collected by 
questionnaire included family demo  graphics, 
medical histories of the child and mother, 
use of personal products, residential history, 
drinking water source, and physical activity 
(Hiatt et al. 2009). A fasting blood sample was 
collected at each visit; a urine sample and self­
administered psychosocial questionnaire were 
collected once a year; and dietary recall inter­
views were conducted quarterly by telephone. 
The urine and blood samples were collected 
using protocols and materials provided by the 
Centers for Disease Control and Prevention 
(CDC). The biologic samples were collected 
for analysis of environmental exposure bio­
markers, hormones, glucose, insulin, lipids, 
and genetic polymorphisms.
The GUF research team consisted of 
university­based researchers and community 
partners who were co­investigators actively 
engaged in the research as well as study staff. 
All members of the research team completed 
human subject research training as required 
by the CCHMC IRB.
The epidemiology study protocol was 
first approved by the CCHMC IRB in July 
2004 and annually thereafter. The consent 
form specified that elevated blood pressure, 
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blood sugar, insulin, and cholesterol would 
be reported to the parents of the study partici­
pants. The consent form did not specify the 
exposure biomarkers to be analyzed, include 
specific language about reporting these results 
to the study families, or include the option 
to decline receipt of test results. However, 
the consent form did state that “The inves­
tigators will tell you about significant new 
findings developed during the course of the 
research and new information that may affect 
your health, welfare or willingness to stay in 
this study.” No Certificate of Confidentiality 
(COC) was in place in the early years of the 
study. Recently, a COC was received that ret­
roactively covers the data collected since the 
inception of the study.
A pilot study was conducted in win­
ter 2006 to determine whether biomarkers 
of exposure could be detected in the study 
girls. Samples obtained in the first year from 
30 girls recruited from each of the three 
BCERC sites were included in the pilot study. 
The other sites included Mount Sinai School 
of Medicine (New York, NY) and Kaiser 
Permanente of northern California (several 
locations in the San Francisco Bay area). The 
urine and serum analyses were conducted by 
the Environmental Health Laboratory at the 
National Center for Environmental Health at 
the CDC. Classes of compounds were selected 
based on their biologic activity, relevance to 
pubertal development, and feasibility. Urine 
samples from all three cohorts were analyzed 
for compounds such as phenols, phthalates, 
phytoestrogens, and cotinine (Wolff et al. 
2007). Blood samples from the northern 
California and Greater Cincinnati cohorts 
were analyzed for compounds such as met­
als, brominated flame retardants, polychlori­
nated biphenyls, and persistent pesticides. At 
the request of the CDC, additional analytes 
not known to be endocrine disruptors at that 
time, such as perfluorochemicals (PFCs), were 
included in the pilot study.
In late winter 2006, the CDC alerted 
our lead epidemiologist that there were 
elevated serum perfluorooctanoate (PFOA) 
levels among girls in the Greater Cincinnati 
cohort compared with the national median 
for older children (12–19 years of age) in the 
1999–2000 National Health and Nutrition 
Examination Survey (NHANES), as meas­
ured by the same CDC laboratory.
PFOA is a common PFC, a class of man­
made compounds extremely resistant to envi­
ronmental degradation. Recent publications 
had reported its detection in the blood of 
humans (Emmett et al. 2006). On closer anal­
ysis, we determined that the elevated results 
belonged to study participants recruited from 
the northern Kentucky school district. We des­
ignated this district community B and the dis­
trict north of the Ohio River in southwestern 
Ohio as community A. For the pilot study, 
the median PFOA value for community B 
(26.4 ng/mL) was significantly higher than 
for community A (7.0 ng/mL). The national 
median value for older children (12–19 years 
of age), based on the 1999–2000 NHANES, 
was 5.6 ng/mL (Calafat et al. 2007). Over the 
next 12 months, the research team sought to 
verify the results, investigate likely sources, 
identify possible health effects, and determine 
what to do with this   unexpected finding.
Methods
In spring–summer 2006, we focused our 
attention on the PFOA findings to determine 
what additional studies and follow­up should 
be conducted. Efforts to identify potential 
sources of exposure were inconclusive. We 
presented our preliminary findings to our 
BCERC colleagues and shared with them our 
concern about how to proceed.
In summer 2006, the research team con­
vened two “biomarker summits.” Attendees 
included members of the research team as well 
as experts in exposure assessment and toxicol­
ogy. The objectives included presentation of the 
pilot study results and environmental samples 
collected at the schools; identification of the 
IRB of record for the pilot study; establishing 
priorities for verifying the pilot study results; 
and developing the components of a commu­
nication strategy. We discussed possible target 
audiences, what results might be reported, and 
how we might report those results.
In fall 2006, serum samples from 15 of 
the original community B pilot study girls and 
from 30 additional girls from the same com­
munity were sent to the CDC. We wanted to 
determine whether the elevated PFOA con­
centrations persisted and whether other study 
girls in community B were affected. Although 
the repeated PFOA concentrations decreased 
between 2005 and 2006 in community B, 
serum levels of 88% of the girls were above 
the NHANES 95th percentile.
We continued to review the scientific lit­
erature for PFOA studies as well as lay media 
sources for information about PFOA contam­
ination. The “Community Exposure to C8 
[PFOA] in the Little Hocking Water Service 
Area Study,” taking place 250 miles up the 
Ohio River from Cincinnati, was particularly 
compelling (Emmett et al. 2006), as drink­
ing water was determined to be the major 
source of exposure (compared with air), and 
the median PFOA blood concentration in 
children 6–10 years of age exceeded all other 
age groups except adults > 60 years of age. 
The U.S. Environmental Protection Agency 
regulators and researchers were contacted to 
learn about environmental sources and prop­
erties of PFOA as well as research address­
ing the biologic effects of exposure. Because 
of ongoing litigation and regulatory review, 
some of those contacted were nonresponsive. 
Online and print media were surveyed for 
information about known environmental 
sources, contamination patterns, and expo­
sure avoidance recommendations. We also 
sought advice from the Silent Spring Institute 
(Newton, MA) and other researchers with 
practical experience reporting exposure bio­
marker results to study participants (Brody 
et al. 2007; Galvez et al. 2007).
As the decision to report the findings to 
the pilot study families evolved, the need for 
a communication plan became apparent. The 
plan needed to be responsive to all the tar­
get audiences, including study families, school 
administrators, health officials, and the media. 
The information needed to be factual, under­
standable, and consistent. It was important to 
use trusted individuals and institutions to com­
municate that plan (Galvez et al. 2007). The 
plan also needed to be comprehensive, antici­
pating questions and reactions that might arise.
The communication plan consisted of:
•	PowerPoint	presentation(s)	tailored	to	dif­
ferent audiences
•	Information packet with fact sheets from 
government web sites
•	Graphs depicting the range of results for a 
sample analyte for each chemical class
•	Graphs depicting the range of PFOA results 
from the pilot study and other references
•	A one­page summary of preliminary GUF 
study findings
•	Glossary of terms
•	Frequently	Asked	Questions	(FAQs)	with	
answers
•	A dedicated phone line for questions from 
study families
•	A press release.
The CCHMC IRB was notified of all 
components of the communication plan. 
Members of the research team developed 
the	FAQs	to	ensure	that	we were prepared 
to address questions likely to arise and that 
our responses were consistent no matter the 
respondent, setting, or target audience.
In May 2007, three family meetings were 
held in the two pilot study communities and 
at CCHMC. In community B, study fami­
lies received a written invitation, and the study 
principal investigator (PI) phoned each family 
to encourage attendance. The study PI, an ado­
lescent medicine physician known to all of the 
study families, presented a study update and the 
biomarker results using PowerPoint slides care­
fully developed by the research team. A tem­
plate was designed that depicted the study data 
points for an analyte for each chemical class. 
For example, brominated diphenyl ether–100 
served as the sample analyte for the brominated 
flames retardants. The 50th and 95th percen­
tiles based on NHANES data recently reported 
by the CDC (Calafat et al. 2007) were included 
on each graph. Our consultations with Silent Sharing biomarker results
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Spring Institute were especially helpful in the 
development of these graphics.
The PFOA findings were presented in a 
graphic that compared the results for commu­
nities A and B with data from the 1999–2000 
NHANES national data set, a Parkersburg, 
West Virginia, cohort, and the San Francisco 
Bay area BCERC cohort. These additional 
data points were intended to provide context 
for the study families to interpret and com­
pare the local data and their child’s results, as 
shown in Figure 1. We used the West Virginia 
data because Parkersburg is < 250 miles up 
the Ohio River from Cincinnati.
Each study family whose child participated 
in the pilot study received a report of the serum 
and urine biomarker results of their child. A 
sample analyte for each chemical class of bio­
marker was presented; the chemical classes 
included phenols, phthalates, cotinine, metals, 
phytoestrogens, brominated flame retardants, 
polychlorinated biphenyls, and persistent pes­
ticides. Perfluorooctane sulfonate and PFOA 
were reported for the PFCs. The median for 
Greater Cincinnati (based on the 30 partici­
pants in communities A and B), national refer­
ences (Calafat et al. 2007; National Center for 
Environmental Health 2005), and the child’s 
result were reported for each analyte.
The handout packet included a list of ref­
erences, a glossary of > 70 terms, and copies 
of web site materials about the different bio­
markers. These materials were downloaded 
from web sites maintained by federal agencies, 
state health agencies, and National Institutes 
of Health–sponsored research programs. The 
CCHMC IRB was notified of all materials 
provided to the study families.
At the meetings, time was allocated for 
questions and answers as well as one­on­one 
and small group discussions facilitated by the 
study PI and co­investigators. PFOA­related 
questions pertained to a) sources, pathways, 
and duration of exposure(s); b) possibility of 
follow­up studies that would include fam­
ily members; c) likelihood of bioaccumula­
tion; d) factors likely associated with higher 
concentrations, such as length of residence; 
e) recommendations for preventing future 
exposures; and f) implications for the puberty 
study. Given the dearth of specific informa­
tion about exposure sources and pathways as 
well as health impacts, attendees asked why 
the information was being emphasized and 
should study families be concerned. Responses 
to these questions sought to allay concerns, 
emphasizing the absence of relevant data, the 
lack of standards, and the multiplicity of con­
sumer products containing this compound.
In community B, the superintendent of 
the school district attended the meeting, hav­
ing been alerted to the results by the study 
PI. The superintendent and several attend­
ees commented that the findings might have 
implications beyond the study families and 
perhaps the county. The superintendent 
remarked that CCHMC is a trustworthy insti­
tution, inferring that there would be   follow­up 
if health concerns came to light.
Three percent of the study families from 
community A and 41% of the study fami­
lies from community B attended the meet­
ings in their respective neighborhood school. 
Seventy­eight percent of the families attending 
the meetings completed a one­page evaluation 
of the program. Respondents generally felt the 
program met their expectations, that the infor­
mation was presented in a manner they could 
understand, and that questions from the audi­
ence were answered satisfactorily. Respondents 
expressed interest in learning more about the 
study findings, both individual and aggre­
gate results, especially from the psychosocial 
questionnaires as well as the exposure bio­
markers, hormone analyses, and maturation 
assessments. As with the topics addressed in 
the question­and­answer period, respondents 
wanted more information about PFOA and 
ongoing updates. We mailed meeting­specific 
information packets to those study families 
who could not attend the meetings.
The UC Department of Public Relations 
and Communications had been alerted in 
advance about the family meetings. A press 
release was drafted should the need arise for 
a more public statement concerning the find­
ings. Soon after the family meetings, mem­
bers of the research team met with relevant 
water district personnel in Greater Cincinnati 
to notify them of the biomarker findings and 
to inquire about the availability of local water 
sample analyses for PFCs. Officials assisted 
us with information about their water intake 
sites along the Ohio River, purification tech­
nologies at each treatment facility, quality 
control standards, and the geographic distri­
bution boundaries of each facility.
Discussion
The research team grappled with the decision 
to communicate the unexpected PFOA find­
ings to the study families. A number of com­
peting and complementary perspectives were 
considered until consensus was reached.
The transdisciplinary model. Trans­
disciplinary science is best described as the 
interactive work of scientists from multiple dis­
ciplines on a common problem with a com­
mon conceptual frame work, resulting in novel 
insights and approaches (Rosenfield 1992). The 
transdisciplinary structure of the BCERC allows 
for the integration of diverse scientific and com­
munity perspectives. The Cincinnati BCERC 
included environmental epidemiologists, an 
adolescent medicine physician, biologists, toxi­
cologists and breast cancer advocates who had 
worked together since the development of the 
research proposal. This diverse group of indi­
viduals brought a variety of expertise, life expe­
riences, and perspectives to the table: 
•	The	researchers	from	the	UC	Department	
of Environmental Health had years of expe­
rience in reporting individual results to 
study participants from pediatric lead expo­
sure studies, medical monitoring programs 
(Wones et al. 2009), and community­based 
participatory research. These were positive 
experiences that gave us a framework to 
design our reporting­back mechanisms.
•	A	 clinical	 perspective	 reflected	 the	
Hippocratic Oath, “Do No Harm,” and 
some team members feared unnecessarily 
Figure 1. Relative exposure communication tool illustrating the differences in serum concentration of PFOA 
in occupational and related community populations, two BCERC cohorts, and the U.S. population; pre-
sented to Cincinnati BCERC Pilot Study Families, May 2007. Communities A and B and the San Francisco 
Bay area cohorts are all part of the BCERCs. Graphic on right is an expansion of selected data from 
graphic on left. Data from Emmett et al. (2006) and Calafat et al. (2007).
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stressing the parents in this nonintervention 
study. These team members argued that it 
was not right for us to give parents informa­
tion about a contaminant where the possible 
health effects of the source(s) or solution(s) 
to limiting exposure were unknown. At that 
time, there was no formalized communica­
tion plan to report back study results except 
elevated lipids, high blood pressure, and at­
risk psychosocial indicators.
•	The	epidemiology	members	of	the	research	
team experienced in population­based stud­
ies had long ago adopted the terminology of 
study participants versus study subjects. The 
term “participant” reinforces individuality 
and argues against the notion that the terms 
are interchangeable. “Study participant” 
implies an active role in which individuals 
are engaged in an exchange of information, 
whereas “study subject” implies a passive 
role in which information is transferred in a 
single direction. This perspective reinforced 
the viewpoint that full disclosure to the 
study families was appropriate.
•	The	scientists	at	the	CDC	Environmental	
Health Laboratory where the analyses had 
been performed supported informing the 
families about these findings. Likewise, col­
leagues within the BCERC network encour­
aged us to discuss these high PFOA levels in 
community B.
•	Ultimately,	it	was	the	breast	cancer	advo­
cates who were a key factor influencing the 
decision of when and how to report results 
back. The advocate members of the research 
team spoke out on behalf of the study fami­
lies. They espoused the concept of a partner­
ship with the study parents and reasoned 
that individuals respect honesty. This per­
spective as a stand­in or proxy parent of 
the girls argued for full disclosure of avail­
able information, even if the source(s) of 
the exposure and the health implications 
were unknown. They also considered the 
study participants and any pregnant family 
members as vulnerable populations because 
of their increased sensitivity to an increased 
body burden due to environmental expo­
sures (Tamburlini et al. 2002).
The precautionary principle and the right 
to know. At the time of our deliberations, the 
health consequences of PFOA were poorly 
understood, no health standard(s) existed, and 
it was unknown whether blood levels reflected 
past or current exposures. Our center was 
at a loss for recommendations as to how to 
remove this chemical from the body. The pre­
cautionary principle encourages policies that 
protect human health in the face of uncer­
tain risks. The precautionary principle states 
that evidence of harm, rather than definitive 
proof of harm, should prompt policy action, 
and that the burden of proof should lie with 
manufacturers to demonstrate that chemicals 
are safe, rather than with the public to show 
that they cause harm (Kriebel et al. 2001). 
We used this principle to guide us as we took 
responsibility to communicate with our study 
families. We had to overcome the fact that we 
did not have all of the answers, but it was our 
responsibility to give study families the infor­
mation we knew at that time, so that they 
could make informed decisions about their 
health and the health of their families. It was 
difficult to recommend any interventions to 
the parents of our study participants. The data 
suggested an air or water pathway, rather than 
product use, because the girls with elevated 
values were limited to one geographic area. 
At the time of the parent meetings, we did 
not know whether the exposure still existed, 
and we explained these gaps in our knowledge 
to them. We did suggest the use of filtered 
water, if they had a concern.
The principles of respect for persons, 
beneficence, and justice shape the conduct 
of research with human subjects (Fernandez 
et al. 2003; National Commission for the 
Protection of Human Subjects of Biomedical 
and Behavioral Research 1979). Right­to­
know regulations addressing exposures of 
workers in workplace settings and residents 
in community settings provided guidance 
for sharing available (although sometimes 
incomplete) information. Study participants 
want to know their results and are naturally 
curious about their environmental exposures 
(Deck and Kosatsky 1999). Study partici­
pants deserve basic information about the risks 
of widely used chemicals that they may be 
exposed to at work, at home, or through their 
food and water (Morello­Frosch et al. 2009).
Potential fallout from reporting results. 
Other factors were discussed as reasons not 
to share the PFOA results to study families at 
that time: 
•	Study	recruitment	was	ongoing, and there was 
concern that these unexpected results could 
negatively influence enrollment and/or reten­
tion of the girls already enrolled in the study.
•	Ongoing	litigation	and	regulatory	review	of	
manufacturing facilities along the Ohio River 
that had disposed of PFOA into the environ­
ment concerned the research team. Public 
release of the biomarker findings might lead 
to Freedom of Information Act requests from 
news media or participants involved in legal 
actions at PFOA contamination sites around 
the country. Members of the research team 
were concerned about the possibility of legal 
challenges that might compromise the ano­
nymity and confidentiality of study families. 
At the time, no COC existed for this study.
•	Accurately	reporting	these	findings	to	study	
families was going to be an extremely time­
consuming task on top of existing day­to­
day study commitments. There were no 
extra funds or support to pay for additional 
items such as retesting serum samples, test­
ing water samples, or hiring support staff.
•	PFOA	biomarkers	were	not	part	of	the	
original BCERC protocol. Because at the 
initiation of the pilot study PFCs were not 
biomarkers of interest in relation to puberty 
or breast cancer, some argued that we had 
no obligation to become involved in some­
thing that was outside our study objectives. 
Because these results had not been published 
in a peer­reviewed journal, there was some 
reticence to release the data.
•	Some	team	members	argued	that	we	were	
not obligated to remedy the situation simply 
because we had encountered an unexplained 
phenomenon (Resnik 2009). 
Conclusions
Human research protocols must adapt as 
scientific methods improve, research stan­
dards evolve, new collaborations with diverse 
stakeholders develop, and community knowl­
edge and expectations change. Our experi­
ence offers an example of communicating an 
unexpected research finding to the families of 
study participants. Although we have not yet 
developed a comprehensive protocol for com­
municating individual results, we have learned 
a number of important lessons for the future.
A realistic assessment of what should and 
can be shared needs to be addressed before 
recruitment begins. The consent form is a 
crucial document that must be developed 
with care, clearly stating what, when, and how 
aggregated and individual data will be com­
municated to whom. The option to opt out of 
receiving all or some of the study results can 
be included in the consent form to accommo­
date the preferences of individual participants. 
A COC should be acquired for the study, 
because it provides protection for study par­
ticipants beyond that provided by the process 
of obtaining informed consent.
Consider forming an advisory committee 
of stakeholders, including study participants. 
This venue can serve to inform the research 
team about expectations of key stake  holders 
vis­à­vis the study and changes in public 
knowledge and opinions about environmental 
exposures and health. It is also an opportunity 
for researchers to educate key stakeholders 
about research, its strengths, its uncertainties, 
and the prolonged time frame.
A good transdisciplinary research team will 
by its very nature reflect a diversity of perspec­
tives. Members can have strong opinions reflec­
tive of their training and experiences, leading to 
vigorous disagreements as to how to proceed. 
Resolution of issues can take many months as 
team members assimilate new information and 
perhaps revise attitudes and approaches. When 
members are willing to listen to these diverse 
opinions and are open to learning and change, 
the dialogue can result in a solution that is Sharing biomarker results
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acceptable to all and benefits the research team, 
study participants, and the general public.
With the transdisciplinary model becom­
ing a frequent research design, all members of 
the research team should be able to inspect and 
review the data so challenging issues—such 
as whether, when, and how to communicate 
research findings—can be discussed openly 
and candidly among all members. Community 
partners, like university­based researchers and 
study staff, should complete all the standard 
training for human subject research so the 
breadth of experience, knowledge, and perspec­
tives of all the members of the transdisciplinary 
team can be accessed. It is our experience that 
those community members will drive the 
“Right to Know” principles and encourage 
open and timely communication when the 
research involves human participants.
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